We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
CCC Intelligent Solutions Holdings Inc. (CCCS - Free Report) provides technology solutions to the property and casualty insurance industry. The Zacks Consensus Estimate for its current year earnings has been revised 14.3% downward over the last 60 days.
BJ's Restaurants, Inc. (BJRI - Free Report) is a chain of casual dining restaurants. The Zacks Consensus Estimate for its current year earnings has been revised 121.4% downward over the last 60 days.
Eagle Pharmaceuticals, Inc. (EGRX - Free Report) is a pharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 33.8% downward over the last 60 days.
Image: Shutterstock
New Strong Sell Stocks for September 1st
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
CCC Intelligent Solutions Holdings Inc. (CCCS - Free Report) provides technology solutions to the property and casualty insurance industry. The Zacks Consensus Estimate for its current year earnings has been revised 14.3% downward over the last 60 days.
BJ's Restaurants, Inc. (BJRI - Free Report) is a chain of casual dining restaurants. The Zacks Consensus Estimate for its current year earnings has been revised 121.4% downward over the last 60 days.
Eagle Pharmaceuticals, Inc. (EGRX - Free Report) is a pharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 33.8% downward over the last 60 days.
View the entire Zacks Rank #5 List.